Stimulation tests for the bone marrow neutrophil pool in malignancies

Leukemia and Lymphoma

Volumn 16, Issue 3-4, 1995, Pages 237-246

  Hansen, Per Boye ^a   Knudsen, Lene Meldgaard ^a   Johnsen, Hans E ^a   Hansen, Niels Ebbe ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cyclic chemotherapy; Marrow cellularity; Myeloid growth factors; Neutrocytosis; Stimulation test

Indexed keywords

ADRENALIN; ANTINEOPLASTIC AGENT; CORTICOSTEROID; ENDOTOXIN; ETIOCHOLANOLONE; LITHIUM CARBONATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

BONE MARROW CELL; CANCER COMBINATION CHEMOTHERAPY; CELL KINETICS; DRUG SCREENING; GRANULOCYTE; HODGKIN DISEASE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; LEUKOCYTOSIS; LYMPHOMA; MYELOPOIESIS; NEUTROPENIA; NEUTROPHIL; NEUTROPHILIA; ORAL DRUG ADMINISTRATION; PREDICTION; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

BONE MARROW; CASE REPORT; COLONY-STIMULATING FACTORS; HUMAN; MALE; METHODS; MIDDLE AGE; NEOPLASMS; NEUTROPHILS; RECOMBINANT PROTEINS; STIMULATION, CHEMICAL;

EID: 0028860235     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199509049763     Document Type: Article

References (46)

1. The chemotherapy of lymphomas: looking back, moving forward—The Richard and Hinda Rosenthal Foundation award lecture
2. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodg-kin's disease: results of a BNLI randomised trial
3. Effect of recombinant granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with urogenital cancer
4. Reduction by granulocyte colony-stimulating factor and neutropenia induced by chemotherapy in patients with small-cell lung cancer
5. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy
6. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: A randomized controlled trial
7. Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas
8. Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils
9. Respiratory burst in adherent human neutrophils: Triggering by colony-stimulating factors CSF-GM and CSF-G
10. Neutrophil migration is defective during recombinant human granulocyte-macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humans
11. Chemotactic activity of recombinant human granulocyte-colony stimulating factor
12. The total blood circulating and marginal granulocyte pool and the granulocyte turnover rate in normal subjects
13. Studies on the life cycle of normal and neoplastic leukocytes by labelling DNA with tritiated thymidine
14. Granulocyto-poiesis
15. Granulocytopoiesis. I. Senescence and random loss of neutrophilic granulocytes in human beings
16. 32
17. In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients
18. Transient leucopenia induced by granulocyte macrophage colony stimulating factor (Letter)
19. The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo
20. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy
21. Granulocyte-macrophage colony-stimulating factor induces the expression of the CD1 lb surface adhesion molecule on human granulocytes in vivo
22. Different membrane expression of CDllb and CD 14 on blood neutrophils following in vivo administration of myeloid growth factors
23. Increased yield of myeloid progenitor cells in bone marrow harvested for autologous transplantation by pretreatment with recombinant human granulocyte-colony stimulating factor
24. Haemopoietic cell kinetics in humans treated with rhGM-CSF
25. The pyogenic effect of etiocholanolone
26. Quantitative aspects of pyrogenic and hematologic responses to etiocholanolone in man
27. The effect of etiocholanolone on granulocyte kinetics
28. The effect of etiocholanolone on the entry of granulocytes into the peripheral blood
29. Correlation of granulocyte mobilization with etiocholanolone and the subsequent development of myelosuppression in patients with acute leukemia re-cieving therapy
30. Etiocholanolone in the evaluation of marrow reserves in patients receiving cytotoxic agents
31. The etiocholanolone test for prediction of the leukopenic effect of cytotoxic drugs
32. Leukokinetic studies. XIII. A non-steady-state kinetic evaluation of the mechanism of cortisone-induced granulocytosis
33. Prednisolone-induced granulocytosis
34. The mechanism of Cortisol induced granulocytosis
35. The intravascular survival of neutrophils labeled in vivo
36. Evaluation of marrow granulocyte reserves in normal and disease states
37. The granulocyte response to endotoxin in patients with hematologic disorders
38. Endotoxin stimulation in patients with lymphoma: Correlation with the myelosuppressive effects of alkylating agents
39. The Piroman test: A useful assay of bone marrow granulocyte reserves
40. Blood neutrophil increment after a single injection of rhG-CSF or rhGM-CSF correlates with marrow cellularity and may predict the grade of neutropenia after chemotherapy
41. The release of leukocytes and platelets from the pulmonary circulation by epinephrine
42. The hematologic response to adrenalin
43. The hematopoietic effects of lithium
44. Effect of lithium on neutrophil mass and production
45. The use of lithium carbonate to reduce infection and leukopenia during systemic chemotherapy
46. Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy